The exact amount of vitamin D required for pregnant women to adequately supply the foetus during pregnancy is still unclear. This randomised trial attempted to determine the optimal dose of vitamin D necessary during pregnancy in order to attain a vitamin D level > 20 ng/mL in neonates. CONCLUSION A vitamin D3 dose > 50,000 IU/month is required during the second and third trimesters of pregnancy for vitamin D-deficient pregnant women in order for their neonates to achieve serum 25(OH)D levels > 20 ng/mL. Supplementation with < 50,000 IU/month is insufficient to ensure a vitamin D level > 20 ng/mL in all neonates born to vitamin D-deficient pregnant women.
INTRODUCTION
Vitamin D inadequacy and deficiency are global problems, and their prevalence is high even in developed countries. In particular, pregnant women have been identified as a high-risk group, with global reports citing that 20%-80% of pregnant women may suffer from vitamin D inadequacy. (1) Evidence from animal studies, with some supportive findings from human studies, suggests that maintaining adequate levels of vitamin D and calcium during pregnancy may decrease the risks of preeclampsia. (2, 3) Moreover,
gestational diabetes mellitus appears to be more common in pregnant women with a low vitamin D status. (2, 3) There is also evidence suggesting that vitamin D-deficient women are at increased risk of bacterial vaginosis and Caesarean sections, (4) both of which have potentially adverse effects on the neonate. Prematurity, low birth weight and lower bone density, as well as later sequelae such as higher rates of lower respiratory tract infection in the first months of life, asthma, diabetes mellitus, autism and dental problems, are examples of neonatal outcomes known to be related to vitamin D deficiency in pregnancy. 
The exact amount of vitamin D required during pregnancy has not been defined. Evidence shows that the recommended dosages of prenatal care vitamins is insufficient to effect a significant change in the serum 25(OH)D levels of pregnant women; in vitamin D-deficient pregnant women, amounts < 1,000 IU could not maintain a sufficient level at the end of pregnancy. (14, 15) Our protocol for vitamin D3 administration in 
ME THODS
The study was carried out on 51 healthy, pregnant women from 
Samples were allocated as 51 (β = 80%; α = 5%; standard deviation = 10; d = 2.
8). Normality of the variable (25[OH]D)
was checked using the Shapiro-Wilk test (Group A, p < 0.05).
The Mann-Whitney U test was used for comparing the means between groups.
RESULTS
The mean age of the participants was 25 ± 3 years. 76% of the pregnant women were either primigravida or secundigravida, and all the participants were educated. Initial measurements of serum 
DISCUSSION
The present study confirms previous reports of high rates of vitamin D deficiency among pregnant women in our region. (20) This is similar to the findings of reports from the region. (20) This deficiency could be due to lifestyle factors such as a preference for indoor activities, the lack of intake of vitamin (20) suggests that this assumption can be extended to the pregnant women in our cohort as well. This finding is in agreement with that of a previous study, (21) but it is at odds with a recent recommendation by the Institute of Medicine of the National Academies, USA, which proposed a daily intake of 400 IU/day during pregnancy. sufficiency at the end of pregnancy. (14) Studies have also suggested that vitamin D deficiency is present even among pregnant women in developed countries, and it is therefore possible that the recommended daily intake of 400 IU/day for such women may only achieve minimal increases in serum 25(OH)D levels even with supplementation. (23, 24) We found that a serum level of 25(OH)D > 20 ng/mL was achievable in all neonates when the pregnant women's intake of vitamin D was increased to 50,000 IU every two weeks (~ 3,300 IU/day), or when an initial bolus dose of 200,000 IU followed by 50,000 IU/month was taken during the course of the pregnancy. A thorough study is required to determine the effectiveness of these two approaches, specifically from a clinical point of view, as well as to assess the long-term effects of such supplementation. Our findings are similar to those of other studies, which reported that vitamin D3 supplementation > 2,000 IU/day is necessary to obtain a sufficient serum level of vitamin D in pregnant women and their neonates. (25, 26) Where other recommendations are concerned, for instance the Canadian Academy of Paediatrics, which recommends a vitamin D supplementation of 2,000 IU/day for the entire duration of pregnancy, (27) it would be better to individually . This is in contrast to the 8% rate of prematurity in our region. (19) We also found that the mean weight of neonates born to women with vitamin D supplementation (mean weight, 3,408 ± 432 g) was higher than that of infants born in Yazd (t-test; 95% CI 189-376; p = 0.0005). These findings are in agreement with recent media reports of a high-quality clinical trial in the USA, where vitamin D was found to be associated with a lower risk of premature birth. (28) This study is, however, not without its limitations. 
